Mesoblast hopes $65m raising will end cash flow ‘chatter’

MELBOURNE: Mesoblast chief executive Silviu Itescu says the biotech’s ability to raise $US45m ($65m) in

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In